Michael Thomas Heffernan is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 48,586 shares of AKBA, which is worth approximately $90,855. The most recent transaction as insider was on Jun 02, 2021, when has been sold 13,700 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.6K
0% 3M change
0% 12M change
Total Value Held $90,855

Michael Thomas Heffernan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 02 2021
BUY
Grant, award, or other acquisition
-
13,700 Added 22.0%
48,586 Common Stock

Also insider at

SYBX
SYNLOGIC, INC. Healthcare
COLL
COLLEGIUM PHARMACEUTICAL, INC Healthcare
BHVN
Biohaven Pharmaceutical Holding Co Ltd. Healthcare
TRVI
Trevi Therapeutics, Inc. Healthcare
BHVN
Biohaven Ltd.
MTH

Michael Thomas Heffernan

New Haven, CT

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Track Activities on AKBA